STONEMEDIC MPC MARBLE POLISHING COMPOUND

Informasi Utama

  • Nama dagang:
  • STONEMEDIC MPC MARBLE POLISHING COMPOUND
  • Digunakan untuk:
  • manusia
  • Jenis Obat:
  • Perangkat medis

Dokumen

  • untuk masyarakat umum:
  • Informasi leaflet untuk produk ini saat ini tidak tersedia, Anda dapat mengirim permintaan untuk layanan pelanggan kami dan kami akan memberitahu Anda segera setelah kami mampu mendapatkannya.


    Meminta selebaran informasi untuk masyarakat umum.

Lokalisasi

  • Tersedia di:
  • STONEMEDIC MPC MARBLE POLISHING COMPOUND
    Indonesia
  • Bahasa:
  • Bahasa Indonesia

Informasi lainnya

Status

  • Sumber:
  • Ecolab
  • Nomor Otorisasi:
  • 911095
  • Pembaharuan Terakhir:
  • 12-03-2018

Ringkasan karakteristik Produk: dosis, interaksi, efek samping

LEMBARAN DATA KESELAMATAN BAHAN

STONEMEDIC MPC MARBLE POLISHING COMPOUND

911095

1 / 8

BAGIAN 1. IDENTIFIKASI SENYAWA (TUNGGAL ATAU CAMPURAN)

Nama Produk

STONEMEDIC MPC MARBLE POLISHING COMPOUND

Cara identifikasi lainnya

Tidak berlaku.

Penggunaan yang dianjurkan

Produk perawatan lantai

Pembatasan penggunaan

Disediakan untuk penggunaan industrial dan profesional.

Informasi pengenceran

produk

Produk dijual siap pakai.

Perusahaan

PT. Ecolab Indonesia

Jl. Jababeka XII Kav V-37

Kawasan Industri jababeka, Cikarang Indonesia 17350

(62-21) 5707557

Nomor telepon darurat

+1-651-222-5352 (Amerika Syarikat)

Tanggal penerbitan pertama

28.08.2014

BAGIAN 2. IDENTIFIKASI BAHAYA

Klasifikasi GHS

Korosif pada logam

Kategori 1

Toksisitas akut (oral)

Kategori 4

Toksisitas akut (Kulit)

Kategori 5

Korosi kulit

Kategori 1A

Kerusakan mata serius

Kategori 1

Elemen label GHS

Piktogram bahaya

Kata sinyal

Bahaya

Pernyataan Berbahaya

Dapat korosif terhadap logam.

Berbahaya jika tertelan.

Mungkin berbahaya jika terkena kulit.

Menyebabkan kulit terbakar yang parah dan kerusakan mata.

Pernyataan Hati-hati

Pencegahan:

Jaga hanya disimpan dalam wadah aslinya. Cuci kulit dengan

seksama setelah menangani. Jangan makan, minum atau merokok

pada saat menggunakan produk ini. Pakai sarung tangan pelindung

/pakaian pelindung /pelindung mata/pelindung wajah.

Respons:

JIKA TERTELAN: Hubungi SENTRA INFORMASI KERACUNAN atau

dokter/tenaga medis jika kamu merasa tidak sehat. JIKA TERTELAN :

Basuh mulut. JANGAN merangsang muntah. JIKA TERKENA KULIT

(atau rambut): Tanggalkan segera semua pakaian yang

terkontaminasi. Bilas kulit dengan air/pancuran. JIKA TERHIRUP:

Pindahkan korban ke udara segar dan posisikan yang nyaman untuk

bernapas. JIKA TERKENA MATA : Bilas dengan seksama dengan air

LEMBARAN DATA KESELAMATAN BAHAN

STONEMEDIC MPC MARBLE POLISHING COMPOUND

911095

2 / 8

untuk beberapa menit. Lepaskan lensa kontak jika memakainya dan

mudah melakukannya.Lanjutkan membilas. Segera hubungi SENTRA

INFORMASI KERACUNAN atau dokter/tenaga medis. Cucilah

pakaian yang terkontaminasi sebelum digunakan kembali. Serap

tumpahan untuk mencegah kerusakan material.

Penyimpanan:

Simpan di tempat terkunci. Simpan dalam wadah stainless steel tahan

korosi dengan lapisan dalam tahan korosi.

Pembuangan:

Buang isi / wadah ke tempat pembuangan limbah yang disetujui.

Bahaya lain

Tidak ada yang diketahui.

BAGIAN 3. KOMPOSISI/INFORMASI TENTANG BAHAN PENYUSUN

Bahan/preparasi murni

Campuran

Nama kimia

No-CAS

Konsentrasi (%)

Organic salt.

127-95-7

60 - 100

Abrasives (Calciumcarbonate)

1344-28-1

10 - 30

fatty acids, vegetable-oil, compds. with

ethanolamine

68783-56-2

5 - 10

DIPROPILENA GLIKOL MONOMETIL ETER

34590-94-8

1 - 5

BAGIAN 4. TINDAKAN PERTOLONGAN PERTAMA PADA KECELAKAAN

Jika kontak dengan mata

Basuhlah segera dengan banyak air, dan berikan air sebanyak-

banyaknya di bawah kelopak mata, sekurangnya selama 15 menit.

Lepas lensa kontak, jika digunakan dan mudah melakukannya.

Lanjutkan membilas. Segera panggil dokter.

Jika kontak dengan kulit

Segera cuci bersih dengan banyak air sedikitnya selama 15 menit.

Gunakan sabun lunak bila tersedia. Cuci pakaian yang tercemar

sebelum dipakai lagi. Cucilah sebersih mungkin sepatu sebelum

dipakai lagi. Segera panggil dokter. Oleskan gel kalsium glukonat, jika

tersedia, atau susu magnesium untuk daerah yang terkena.

Jika tertelan

Berkumurlah dengan air. JANGAN pancing supaya muntah. Jangan

sekali-kali memberikan apa pun lewat mulut kepada orang yang tidak

sadar. Segera panggil dokter. Jika tersedia, ambil beberapa tablet

'calcium antacid' (Contoh: Tums) atau beberapa sendok makan 'milk

of magnesia'

Jika terhirup

Pindahkan ke tempat berudara segar. Tangani menurut gejala.

Tangani secara medis jika muncul gejala.

Perlindungan aiders pertama

Bila ada bahaya kontaminasi lihat bab 8 tentang perlengkapan

melindungi diri.

Instruksi kepada dokter

Tangani menurut gejala.

Lihat informasi toksikologi (bagian 11)

BAGIAN 5. TINDAKAN PEMADAMAN KEBAKARAN

Media pemadam yang sesuai

Gunakan tindakan pemadaman kebakaran yang sesuai untuk situasi

lokal dan lingkungan sekitar.

LEMBARAN DATA KESELAMATAN BAHAN

STONEMEDIC MPC MARBLE POLISHING COMPOUND

911095

3 / 8

Zat pemadam kebakaran

yang tidak sesuai

Tidak ada yang diketahui.

Bahaya spesifik yang

diakibatkan bahan kimia

tersebut

Eksposur terhadap produk-produk dekomposisi dapat berbahaya bagi

kesehatan.

Produk pembakaran

berbahaya

Hasil penguraian mungkin termasuk bahan-bahan berikut:

Karbon oksida

Alat pelindung khusus bagi

petugas pemadam

kebakaran

Gunakan alat pelindung diri.

Metode pemadaman khusus

Residu kebakaran dan air bekas pemadam kebakaran yang tercemar

harus dibuang sesuai dengan peraturan lokal. Jika terjadi kebakaran

dan/atau ledakan, jangan menghirup asap.

BAGIAN 6. TINDAKAN PENANGGULANGAN JIKA TERJADI TUMPAHAN DAN KEBOCORAN

Tindakan pencegahan

pribadi, peralatan pelindung

dan prosedur darurat

Pastikan ventilasi memadai. Jauhkan orang dari tumpahan/bocoran ke

arah yang berlawanan dengan arah angin. Hindari penghirupan,

penelanan dan kontak langsung dengan kulit dan mata. Jika karyawan

menghadapi konsentrasi yang melebihi ambang batas pajanan,

mereka harus memakai alat bantu pernapasan yang memenuhi

standar. Pastikan agar pembersihan dilakukan hanya oleh petugas

terlatih. Mengaculah pada langkah-langkah perlindungan yang

dicantumkan dalam seksi 7 dan 8.

Tindakan pencegahan untuk

melindungi lingkungan

Jangan sampai mengenai tanah, air permukaan atau air tanah.

Metode dan bahan untuk

penyimpanan dan

pembersihan

Hentikan kebocoran jika aman untuk melakukannya.Tahan dan

kumpulkan tumpahan dengan bahan penyerap yang tidak mudah

terbakar (misalnya pasir, tanah, tanah diatomaceus, vermiculite) dan

tempatkan dalam kontener untuk dibuang berdasarkan peraturan

lokal/nasional (lihat seksi 13).Siramlah sisa-sisa dengan air.Untuk

tumpahan dalam jumlah banyak, bendung tumpahan bahan atau

tumpahan yang mengandung bahan materi untuk memastikan agar

tidak mengalir menuju saluran air.

BAGIAN 7. PENANGANAN DAN PENYIMPANAN

saran penanganan yang

aman

Jangan dimakan. Jangan menghirup

debu/asap/gas/kabut/uap/semburan. Gunakan hanya dengan ventilasi

yang cukup. Cucilah tangan bersih-bersih setelah menangani. Jangan

terkena mata, kulit atau pakaian.

Kondisi untuk penyimpanan

yang aman

Jauhkan dari jangkauan anak-anak. Jaga wadah tertutup rapat.

Simpan dalam wadah yang berlabel sesuai.

Suhu penyimpanan

0 °C ke 50 °C

BAGIAN 8. KONTROL PAPARAN/ PERLINDUNGAN DIRI

Komponen dengan parameter pengendalian di tempat kerja

LEMBARAN DATA KESELAMATAN BAHAN

STONEMEDIC MPC MARBLE POLISHING COMPOUND

911095

4 / 8

Komponen

No-CAS

Bentuk

eksposur

Konsentrasi yang

diizinkan

Basis

Abrasives (Calciumcarbonate)

1344-28-1

(Inhalabel)

10 mg/m3

ID OEL

DIPROPILENA GLIKOL

MONOMETIL ETER

34590-94-8

100 ppm

606 mg/m3

ID OEL

150 ppm

909 mg/m3

ID OEL

Pengendalian teknik yang

sesuai

Sistem ventilasi pembuangan yang efektif. Jaga konsentrasi udara di

bawah standar paparan okupasional.

Alat Pelindung Diri

Perlindungan mata

Katamata pelindung keamanan

Topeng-wajah

Perlindungan tangan

Kenakan perlengkapan perlindungan pribadi berikut ini:

Jenis sarung tangan standar.

Sarung tangan harus dibuang atau diganti apabila terdapat indikasi

mengalami degradasi atau kebocoran kimia.

Perlindungan kulit

Peralatan pelindung personal terdiri atas: sarung tangan pelindung,

kacamata keselamatan kerja dan baju pelindung

Perlindungan pernapasan

Jika karyawan menghadapi konsentrasi yang melebihi ambang batas

pajanan, mereka harus memakai alat bantu pernapasan yang

memenuhi standar.

Tindakan higienis

Tangani sesuai dengan praktik kebersihan dan keselamatan industri

yang baik. Lepaskan dan cuci pakaian yang tercemar sebelum dipakai

lagi. Cuci muka, tangan dan kulit yang terpapar dengan seksama

setelah menangani. Menyediakan fasilitas untuk cepat membasahi

atau pembilasan pada mata dan tubuh pada kasus kontak atau

bahaya lain.

BAGIAN 9. SIFAT FISIKA DAN KIMIA

Tampilan

: pasta

Warna

: buram, kuning-kecoklatan

: sitrus

1.5 - 2.5, 1 %

Titik nyala

Tidak berlaku.

Ambang Bau

Data tidak tersedia

Titik lebur/titik beku

Data tidak tersedia

Titik didih awal/rentang didih

> 100 °C

Laju penguapan

Data tidak tersedia

Flamabilitas (padatan, gas)

Data tidak tersedia

Tertinggi batas ledakan

Data tidak tersedia

Terendah batas ledakan

Data tidak tersedia

Tekanan uap

Data tidak tersedia

LEMBARAN DATA KESELAMATAN BAHAN

STONEMEDIC MPC MARBLE POLISHING COMPOUND

911095

5 / 8

Kerapatan (densitas) uap

relatif

Data tidak tersedia

Berat jenis relatif

1.4 - 1.8

Kelarutan dalam air

agak larut

Kelarutan dalam pelarut lain

Data tidak tersedia

Koefisien partisi (n-

oktanol/air)

Data tidak tersedia

Suhu dapat membakar

sendiri (auto-ignition

temperature)

Data tidak tersedia

Suhu penguraian

Data tidak tersedia

Viskositas, kinematis

Data tidak tersedia

Sifat peledak

Data tidak tersedia

Sifat oksidator

Data tidak tersedia

Berat Molekul

Data tidak tersedia

Data tidak tersedia

BAGIAN 10. STABILITAS DAN REAKTIFITAS

Stabilitas kimia

Stabil pada kondisi normal.

Kemungkinan reaksi

berbahaya

Tidak ada reaksi berbahaya yang diketahui dalam kondisi

penggunaan normal.

Kondisi yang harus dihindari

Tidak ada yang diketahui.

Bahan non-kompatibel

Basa

Produk berbahaya hasil

peruraian

Hasil penguraian mungkin termasuk bahan-bahan berikut:

Karbon oksida

BAGIAN 11. INFORMASI TOKSIKOLOGI

Informasi tentang rute

paparan

Penghirupan, Kena mata, Kena kulit

Kemungkinan Dampak Kesehatan

Mata

Menyebabkan kerusakan mata yang serius.

Kulit

Mungkin berbahaya jika terkena kulit. Menimbulkan sensasi terbakar

yang parah pada kulit.

Tertelan

Berbahaya jika tertelan. Menyebabkan sensasi terbakar pada saluran

pencernaan.

Penghirupan

Dapat menyebabkan iritasi saluran pernafasan. Dapat menyebabkan

iritasi pada hidung, tenggorokan, dan paru-paru.

Eksposur Kronis

Gangguan kesehatan tidak diketahui atau tidak diperkirakan jika

penggunaannya normal.

Pengalaman dengan paparan pada manusia

LEMBARAN DATA KESELAMATAN BAHAN

STONEMEDIC MPC MARBLE POLISHING COMPOUND

911095

6 / 8

Kena mata

Kemerahan, Nyeri, Korosi

Kena kulit

Kemerahan, Nyeri, Korosi

Tertelan

Korosi, Sakit perut

Penghirupan

Iritasi alat pernafasan, Batuk

Toksisitas

Toksisitas oral akut

: Perkiraan toksisitas akut : 599.98 mg/kg

Toksisitas inhalasi akut

: Data tidak tersedia

Toksisitas kulit akut

: Perkiraan toksisitas akut : 2,400 mg/kg

Kerusakan/gangguan kulit

Data tidak tersedia

Gangguan mata/kerusakan

mata serius

Data tidak tersedia

Sensitisasi sistem

pernafasan atau kulit

Data tidak tersedia

Karsinogenisitas

Data tidak tersedia

Pengaruh pada alat

reproduksi

Data tidak tersedia

Mutagenitas sel germinal

Data tidak tersedia

Teratogenisitas

Data tidak tersedia

STOT - paparan tunggal

Data tidak tersedia

STOT - paparan berulang

Data tidak tersedia

Derajat keracunan melalui

pernapasan

Data tidak tersedia

BAGIAN 12. INFORMASI EKOLOGI

Derajat racun bagi lingkungan (ekotoksisitas)

Dampak lingkungan

Produk ini tidak mempunyai dampak racun lingkungan yang diketahui.

Produk

Keracunan untuk ikan

: Data tidak tersedia

Derajat racun bagi daphnia

dan binatang tak bertulang

belakang lainnya yang hidup

dalam air.

: Data tidak tersedia

Keracunan untuk ganggang

: Data tidak tersedia

Komponen

Keracunan untuk ikan

: DIPROPILENA GLIKOL MONOMETIL ETER

96 h LC50 Ikan: > 1,000 mg/l

Komponen

Derajat racun bagi daphnia

dan binatang tak bertulang

belakang lainnya yang hidup

: Organic salt.

48 h LC50 Daphnia (Kutu air) : 137 mg/l

LEMBARAN DATA KESELAMATAN BAHAN

STONEMEDIC MPC MARBLE POLISHING COMPOUND

911095

7 / 8

dalam air.

Ketahanan dan tingkat penguraian

Data tidak tersedia

Potensi penumpukan biologis

Data tidak tersedia

Mobilitas di dalam tanah

Data tidak tersedia

Dampak merugikan lainnya

Data tidak tersedia

BAGIAN 13. PERTIMBANGAN PEMBUANGAN/ PEMUSNAHAN

Metode pembuangan

Jika mungkin, pendauran-ulang lebih disukai daripada pembuangan

atau pembakaran. Jika proses daur-ulang tidak praktis, buang sesuai

dengan peraturan lokal. Buanglah sampah dalam fasilitas

pembuangan sampah yang disetujui.

Pembuangan limbah

Buang sebagai produk yang tidak digunakan. Wadah kosong harus

dibawa ke tempat penanganan limbah yang telah disetujui untuk

didaur-ulang atau dibuang. Dilarang menggunakan kembali

kemasan/wadah yang sudah kosong.

BAGIAN 14. INFORMASI PENGANGKUTAN

Pengangkut/ pengirim barang/ pengirim bertanggung jawab untuk memastikan kemasan, label, dan

penandaan yang sesuai dengan jenis transportasi yang digunakan.

Transpor jalan

Bukan barang berbahaya

Transpor laut (IMDG/IMO)

Bukan barang berbahaya

BAGIAN 15. INFORMASI YANG BERKAITAN DENGAN REGULASI

Regulasi domestik

Sistem Harmonisasi Global Klasifikasi dan Label Pada Bahan Kimia (87/M-IND/PER/9/2009)

Komponen-komponen produk ini dilaporkan dalam inventorisasi berikut:

1907/2006 (Uni Eropa) :

belum ditentukan

Swiss. Senyawa yang baru diumumkan dan preparat yang baru dilaporkan :

Sesuai dengan inventaris

Inventaris TSCA Amerika Serikat :

Pada Inventaris TSCA

Daftar Senyawa Domestik Kanada :

Seluruh komponen produk ini terdapat pada daftar DSL Kanada.

Australia. Undang-undang (Pengkajian dan Pemberitahuan) Kimia Industri :

belum ditentukan

LEMBARAN DATA KESELAMATAN BAHAN

STONEMEDIC MPC MARBLE POLISHING COMPOUND

911095

8 / 8

Selandia Baru. Inventaris Bahan Kimia (NZIoC), seperti yang diterbitkan oleh ERMA Selandia

Baru :

belum ditentukan

Jepang. ENCS - Inventaris Senyawa Kimia Yang Sudah Ada Dan Yang Baru :

belum ditentukan

Jepang. ISHL - Inventaris Senyawa Kimia (METI) :

belum ditentukan

Korea. Inventaris Bahan Kimia Yang Sudah Ada (KECI) :

Sesuai dengan inventaris

Inventaris Bahan Kimia dan Senyawa Kimia Filipina (PICCS) :

Sesuai dengan inventaris

Cina. Inventaris Senyawa Kimia yang Sudah Ada :

Sesuai dengan inventaris

BAGIAN 16. INFORMASI LAIN

Tanggal penerbitan pertama

28.08.2014

Versi

Disiapkan oleh

Urusan peraturan

Perbahan-perubahan peraturan atau informasi kesehatan yang signifikan dalam revisi ini ditunjukkan

oleh batang di bagian sisi kiri MSDS.

Informasi yang diberikan dalam Lembar Data Keselamatan ini benar menurut pengetahuan, informasi,

dan keyakinan kami pada tanggal penerbitan. Informasi yang diberikan dimaksudkan hanya sebagai

pedoman untuk penanganan, penggunaan, pemprosesan, penyimpanan, pengangkutan,

pembuangan, dan pembebasan yang aman dan tidak boleh dianggap sebagai jaminan atau

spesifikasi mutu. Informasi hanya menyangkut bahan spesifik yang telah ditentukan dan dapat tidak

berlaku jika bahan tersebut digunakan sebagai campuran dengan bahan lain atau dalam proses lain

kecuali jika dinyatakan secara spesifik dalam tulisan.

1-2-2019


Committee for Herbal Medicinal Products (HMPC): 14-16 January 2019, European Medicines Agency, London, UK, from 14/01/2019 to 16/01/2019

Committee for Herbal Medicinal Products (HMPC): 14-16 January 2019, European Medicines Agency, London, UK, from 14/01/2019 to 16/01/2019

Committee for Herbal Medicinal Products (HMPC): 14-16 January 2019, European Medicines Agency, London, UK, from 14/01/2019 to 16/01/2019

Europe - EMA - European Medicines Agency

31-1-2019

Manual for reporting on antimicrobial resistance within the framework of Directive 2003/99/EC and Decision 2013/652/EU for information derived from the year 2018

Manual for reporting on antimicrobial resistance within the framework of Directive 2003/99/EC and Decision 2013/652/EU for information derived from the year 2018

Published on: Wed, 30 Jan 2019 This manual provides guidance for reporting antimicrobial resistance under the framework of Directive 2003/99/EC and Commission Implementing Decision 2013/652/EU in food‐producing animals and foodstuffs derived thereof. The objective is to harmonise and streamline the reporting made by the Member States to ensure that the antimicrobial resistance data collected are relevant and easy to analyse at the European Union level. Detailed guidelines are provided for the reporting ...

Europe - EFSA - European Food Safety Authority EFSA Journal

25-1-2019

Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 9: suitability of taxonomic units notified to EFSA until September 2018

Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 9: suitability of taxonomic units notified to EFSA until September 2018

Published on: Thu, 24 Jan 2019 The qualified presumption of safety (QPS) procedure was developed to provide a harmonised generic pre‐evaluation to support safety risk assessments of biological agents performed by EFSA's Scientific Panels. The taxonomic identity, body of knowledge, safety concerns and antimicrobial resistance were assessed. Safety concerns identified for a taxonomic unit are, where possible and reasonable in number, reflected by ‘qualifications’ which should be assessed at the strain lev...

Europe - EFSA - European Food Safety Authority EFSA Journal

22-1-2019

Modification of the existing maximum residue levels for tetraconazole in kaki/Japanese persimmon, linseeds and poppy seeds

Modification of the existing maximum residue levels for tetraconazole in kaki/Japanese persimmon, linseeds and poppy seeds

Published on: Mon, 21 Jan 2019 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Isagro S.p.A submitted a request to the competent national authority in Italy to modify the existing maximum residue levels (MRLs) for the active substance tetraconazole in various crops and animal commodities. The data submitted in support of the request were found to be sufficient to derive MRL proposals for tetraconazole in kaki/Japanese persimmon, linseeds and poppy seeds. Adequate analytical me...

Europe - EFSA - European Food Safety Authority EFSA Journal

19-1-2019

Safety for the environment of vitamin D3 for salmonids

Safety for the environment of vitamin D3 for salmonids

Published on: Thu, 17 Jan 2019 The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP Panel) of EFSA assessed the safety for the target species and the consumer of the use of a maximum total level of 1.5 mg vitamin D3/kg feed in fish nutrition (2017). The assessment was based on data that had been provided by the Norwegian Food Safety Authority (NFSA). Since the data set provided by the NFSA did not include any new information concerning the safety for the user and the environment...

Europe - EFSA - European Food Safety Authority EFSA Journal

17-1-2019

Safety and efficacy of 8‐mercapto‐p‐menthan‐3‐one and p‐menth‐1‐ene‐8‐thiol belonging to chemical group 20 when used as flavourings for all animal species

Safety and efficacy of 8‐mercapto‐p‐menthan‐3‐one and p‐menth‐1‐ene‐8‐thiol belonging to chemical group 20 when used as flavourings for all animal species

Published on: Wed, 16 Jan 2019 Following a request from the European Commission, the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of two compounds belonging to chemical group 20 (aliphatic and aromatic mono‐ and di‐thiols and mono‐, di‐, tri‐, and polysulfides with or without additional oxygenated functional groups). 8‐Mercapto‐p‐menthan‐3‐one [12.038] and p‐menth‐1‐ene‐8‐thiol [12.085] are currently ...

Europe - EFSA - European Food Safety Authority EFSA Journal

15-1-2019

Setting of an import tolerance for spiromesifen in coffee beans

Setting of an import tolerance for spiromesifen in coffee beans

Published on: Mon, 14 Jan 2019 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Bayer CropScience submitted a request to the competent national authority in Greece to set an import tolerance for the active substance spiromesifen in coffee beans. The data submitted in support of the request were found to be sufficient to derive a maximum residue level (MRL) proposal for coffee beans. Adequate analytical methods for enforcement are available to control the residues of spiromesife...

Europe - EFSA - European Food Safety Authority EFSA Journal

4-1-2019

Modification of the existing maximum residue levels for lambda‐cyhalothrin in celeries, fennel and rice

Modification of the existing maximum residue levels for lambda‐cyhalothrin in celeries, fennel and rice

Published on: Thu, 03 Jan 2019 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Syngenta Crop Protection AG submitted a request to the competent national authority in Greece to modify the existing maximum residue levels (MRLs) for lambda‐cyhalothrin in celeries, fennel and rice. The data submitted in support of the request were found to be sufficient to derive tentative MRL proposals for the concerned crops. They are tentative as formally the general data gap identified in the ...

Europe - EFSA - European Food Safety Authority EFSA Journal

20-12-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds

Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds

Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds

FDA - U.S. Food and Drug Administration

17-12-2018

December 13, 2018: Owner and Four Former Employees of New England Compounding Center Convicted Following Trial

December 13, 2018: Owner and Four Former Employees of New England Compounding Center Convicted Following Trial

December 13, 2018: Owner and Four Former Employees of New England Compounding Center Convicted Following Trial

FDA - U.S. Food and Drug Administration

14-12-2018

Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

Published on: Thu, 13 Dec 2018 The European Commission asked EFSA for a scientific evaluation on the risks to human health related to the presence of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in food. Regarding PFOS and PFOA occurrence, the final data set available for dietary exposure assessment contained a total of 20,019 analytical results (PFOS n = 10,191 and PFOA n = 9,828). There were large differences between upper and lower bound exposure due to analytical methods with i...

Europe - EFSA - European Food Safety Authority Publications

10-12-2018

Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram on new efforts to assure the quality of compounded drugs

Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram on new efforts to assure the quality of compounded drugs

FDA releases guidance with recommendations for protecting patients from the risk of contaminated or substandard compounded products produced by outsourcing facilities.

FDA - U.S. Food and Drug Administration

30-11-2018


Draft guideline on core SmPC for human plasma derived and recombinant coagulation factor IX products - Revision 3

Draft guideline on core SmPC for human plasma derived and recombinant coagulation factor IX products - Revision 3

Draft guideline on core SmPC for human plasma derived and recombinant coagulation factor IX products - Revision 3

Europe - EMA - European Medicines Agency

25-10-2018

Safety of zinc chelate of methionine sulfate for the target species

Safety of zinc chelate of methionine sulfate for the target species

Published on: Wed, 24 Oct 2018 00:00:00 +0200 Zinc chelate of methionine sulfate is intended to be used as a nutritional additive (functional group: compounds of trace elements). The additive is zinc chelated with methionine in a molar ratio 1:1. It is intended to supply zinc as a nutritional additive to all animal species/categories. In 2017, the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) adopted an opinion on the safety and efficacy of zinc chelate of methionine su...

Europe - EFSA - European Food Safety Authority Publications

22-10-2018

October 22, 2018: Medical Equipment Company Agrees to Pay $5.25 Million to Resolve Allegations of Fraudulent Claims for Compounded Medical Creams

October 22, 2018: Medical Equipment Company Agrees to Pay $5.25 Million to Resolve Allegations of Fraudulent Claims for Compounded Medical Creams

October 22, 2018: Medical Equipment Company Agrees to Pay $5.25 Million to Resolve Allegations of Fraudulent Claims for Compounded Medical Creams

FDA - U.S. Food and Drug Administration

27-9-2018

Outcome of the consultation on confirmatory data used in risk assessment for the active substance  copper (I), copper (II) variants

Outcome of the consultation on confirmatory data used in risk assessment for the active substance copper (I), copper (II) variants

Published on: Wed, 26 Sep 2018 00:00:00 +0200 The European Food Safety Authority (EFSA) was asked by the European Commission to provide scientific assistance with respect to the risk assessment for an active substance in light of confirmatory data requested following the first approval in accordance with Article 6(1) of Directive 91/414/EEC and Article 6(f) of Regulation (EC) No 1107/2009. In this context EFSA's scientific views on the specific points raised during the commenting phase conducted with Me...

Europe - EFSA - European Food Safety Authority Publications

25-9-2018

Remarks from Anna Abram as prepared for delivery to the 2018 Intergovermental Meeting on Drug Compounding

Remarks from Anna Abram as prepared for delivery to the 2018 Intergovermental Meeting on Drug Compounding

Remarks by FDA’s Anna Abram to the 2018 Intergovermental Meeting on Drug Compounding

FDA - U.S. Food and Drug Administration

21-9-2018

FDA Animal Drug Safety Communication: FDA Reminds Veterinarians of the Differences Between Approved and Compounded Formulas of Transdermal Mirtazapine for the Management of Weight Loss in Cats

FDA Animal Drug Safety Communication: FDA Reminds Veterinarians of the Differences Between Approved and Compounded Formulas of Transdermal Mirtazapine for the Management of Weight Loss in Cats

CVM Update describing FDA Dear Veterinarian Letter about the differences between FDA-approved Mirataz (mirtazapine transdermal ointment), an animal drug with demonstrated safety and effectiveness to manage undesired weight loss in cats, and compounded formulations of transdermal mirtazapine.

FDA - U.S. Food and Drug Administration

14-9-2018

Development of an automated multienzymatic biosensor for risk assessment of pesticide contamination in water and food

Development of an automated multienzymatic biosensor for risk assessment of pesticide contamination in water and food

Published on: Mon, 27 Aug 2018 00:00:00 +0200 The goal of this research is to better address the problems related to the widespread presence of pesticides in the environment. Despite the unquestionable utility of the pesticides against various pests in the agricultural field, most pesticides and the corresponding pesticide residues are toxic to the environment and hazardous to human health. The recent literature on organophosphate compounds emphasises a clear correlation between their use and the occurr...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Risk assessment of white willow (Salix alba) in food

Risk assessment of white willow (Salix alba) in food

Published on: Tue, 28 Aug 2018 00:00:00 +0200 This Technical Report contains a description of the activities within the work programme of the EU‐FORA Fellowship on the risk assessment of white willow in food. The bark of different varieties of willow has had a long history of medical use as a means to reduce fever and as a painkiller. Willow bark is also used in weight loss and sports performance food supplements. The labelling of these products usually does not mention any restrictions to the length of...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Risk ranking of chemical and microbiological hazards in food

Risk ranking of chemical and microbiological hazards in food

Published on: Mon, 27 Aug 2018 00:00:00 +0200 Risk ranking is a versatile tool used to prioritise activities performed by public health regulatory bodies. It also allows efficient communication between all stakeholders in the process of risk analysis. However, risk ranking methods are still not optimal. Because of the different approaches employed in the risk assessment of microbiological agents and chemicals, it is difficult to rank them together using the same metrics. In our work, we first discuss di...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Identification and evaluation of potentially mutagenic and carcinogenic food contaminants

Identification and evaluation of potentially mutagenic and carcinogenic food contaminants

Published on: Mon, 27 Aug 2018 00:00:00 +0200 Heat processing of food gives rise to a plethora of chemical compounds whose toxicological effects are largely unknown. Due to a general lack of experimental toxicological data, assessing the risks associated with the consumption of these substances remains a challenge. Computer models that allow for an in silico prediction of physicochemical and toxicological characteristics, may be able to fill current data gaps and facilitate the risk assessment of toxico...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of all Sterile Compounded Drugs Due to A Potential Lack of Sterility Assurance

Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of all Sterile Compounded Drugs Due to A Potential Lack of Sterility Assurance

Pharm D Solutions, LLC is voluntarily recalling all sterile compounded drug products within expiry to the clinic, physician or consumer level. These drug products are being voluntarily recalled due to concerns that practices at the pharmacy have the potential to pose a risk of contamination to products that are intended to be sterile. These concerns arose following a routine inspection of the pharmacy by FDA.

FDA - U.S. Food and Drug Administration

7-9-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to help ensure the quality of and preserve access to compounded drugs by pursuing closer collaboration with states

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to help ensure the quality of and preserve access to compounded drugs by pursuing closer collaboration with states

FDA announces revised draft memorandum of understanding between FDA and the states to help ensure the quality of and preserve access to compounded drugs

FDA - U.S. Food and Drug Administration

29-8-2018

Scientific Opinion on the state of the art of Toxicokinetic/Toxicodynamic (TKTD) effect models for regulatory risk assessment of pesticides for aquatic organisms

Scientific Opinion on the state of the art of Toxicokinetic/Toxicodynamic (TKTD) effect models for regulatory risk assessment of pesticides for aquatic organisms

Published on: Thu, 23 Aug 2018 00:00:00 +0200 Following a request from EFSA, the Panel on Plant Protection Products and their Residues (PPR) developed an opinion on the state of the art of Toxicokinetic/Toxicodynamic (TKTD) models and their use in prospective environmental risk assessment (ERA) for pesticides and aquatic organisms. TKTD models are species‐ and compound‐specific and can be used to predict (sub)lethal effects of pesticides under untested (time‐variable) exposure conditions. Three differen...

Europe - EFSA - European Food Safety Authority Publications

20-8-2018

August 17, 2018: Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center

August 17, 2018: Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center

August 17, 2018: Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center

FDA - U.S. Food and Drug Administration

14-8-2018

Scientific guideline:  Procedure for the review and revision of European Union herbal monographs and European Union list entries - Revision 2, adopted

Scientific guideline: Procedure for the review and revision of European Union herbal monographs and European Union list entries - Revision 2, adopted

The purpose of this procedure is to enable a consistent and proportionate process in reviewing and revising all European Union herbal monographs and European Union list entries adopted by the HMPC. The aim of this document is to describe how to identify the criteria/reasons that trigger the revision of European Union herbal monographs and list entries and the associated procedure and timelines for both the review and the revision.

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2018

Ranier’s Rx Laboratory Issues Voluntary Recall of All Sterile Compounded Products Within Expiry Due to Lack of Sterility Concerns

Ranier’s Rx Laboratory Issues Voluntary Recall of All Sterile Compounded Products Within Expiry Due to Lack of Sterility Concerns

Ranier’s Rx Laboratory is voluntarily recalling all sterile compounded drug products within expiry to the hospital or consumer level. These drug products are being voluntarily recalled due to concerns that practices at the pharmacy have the potential to pose a risk of contamination to products that are intended to be sterile. These concerns arose following a routine inspection of the pharmacy by FDA.

FDA - U.S. Food and Drug Administration

23-7-2018

FDA continues taking key actions on bulk drug substances used for compounding to advance the regulatory framework governing compounded drugs and to protect patients

FDA continues taking key actions on bulk drug substances used for compounding to advance the regulatory framework governing compounded drugs and to protect patients

FDA continues making progress on bulk drug substances for compounding

FDA - U.S. Food and Drug Administration

28-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug

FDA - U.S. Food and Drug Administration

15-6-2018

Compounded Products Containing Triamcinolone-Moxifloxacin by Guardian Pharmacy Services (Dallas, Texas): Alert to Health Professionals - Adverse Events Reported After Receiving Eye Injections

Compounded Products Containing Triamcinolone-Moxifloxacin by Guardian Pharmacy Services (Dallas, Texas): Alert to Health Professionals - Adverse Events Reported After Receiving Eye Injections

At least 43 patient reported adverse event after receiving eye injections of Guardian’s Pharmacy Services compounded triamcinolone-moxifloxacin product during cataract surgery. The patients reportedly experienced various symptoms, including vision impairment, poor night vision, loss of color perception, and significant reductions in best-corrected visual acuity and visual fields. FDA identified multiple substances in Guardian’s product, including poloxamer 407 and poloxamer 407 degradants. FDA prepared i...

FDA - U.S. Food and Drug Administration

27-4-2018

ANSES assesses the efficacy and safety of alternatives to antibiotics in animal husbandry and considers the need for a specific status for these products

ANSES assesses the efficacy and safety of alternatives to antibiotics in animal husbandry and considers the need for a specific status for these products

Today, the Agency is publishing an inventory of alternatives to antibiotics aimed at reducing their use in animal husbandry and based on an original method for evaluating the diverse scientific publications in the field. In its report, ANSES identifies numerous products and substances including compounds, plants, plant extracts and micro-organisms, which are used as alternatives to antibiotics. However, it emphasises the diversity of the data available to assess their safety and efficacy, and their abili...

France - Agence Nationale du Médicament Vétérinaire

17-4-2018

March 27, 2018: Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud

March 27, 2018: Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud

March 27, 2018: Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud

FDA - U.S. Food and Drug Administration

8-9-2009

Decision on future reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium compounds)

Decision on future reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium compounds)

On 3 september 2009, the Danish Medicines Agency decided on the future reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium compounds).

Danish Medicines Agency

24-7-2018

 Minutes of the HMPC 26-27 March 2018 meeting

Minutes of the HMPC 26-27 March 2018 meeting

Committee on Herbal Medicinal Products (HMPC) minutes for the meeting on 26-27 March 2018

Europe - EMA - European Medicines Agency

23-7-2018

Agenda:  Agenda - HMPC agenda of the 23-24 July 2018 meeting

Agenda: Agenda - HMPC agenda of the 23-24 July 2018 meeting

Europe - EMA - European Medicines Agency

27-6-2018

Regulatory and procedural guideline:  Quality Review of Documents general principles regarding the summary-of-product-characteristics information for a generic / hybrid / biosimilar product

Regulatory and procedural guideline: Quality Review of Documents general principles regarding the summary-of-product-characteristics information for a generic / hybrid / biosimilar product

This document outlines the general principles to follow for the preparation of the summary of product characteristics (SmPC) for a generic, hybrid or biosimilar medicinal product to be authorised via the centralised procedure using a reference medicinal product authorised either at national level or centrally.

Europe - EMA - European Medicines Agency

11-6-2018

Agenda:  Agenda - HMPC agenda of the 4-5 June 2018 meeting

Agenda: Agenda - HMPC agenda of the 4-5 June 2018 meeting

Europe - EMA - European Medicines Agency

28-5-2018

 Minutes of the HMPC 29-30 January 2018 meeting

Minutes of the HMPC 29-30 January 2018 meeting

Europe - EMA - European Medicines Agency